Therefore, the decrease in CD44+ CSCs in invasive GL261 tumors in p65 KO mice compared to controls could be the result of the anti-tumor effect of CD8+T cells in syngeneic GBM model. The gene discussed is CD8A; the disease is glioblastoma.